Beta Bionics, Inc. cotiza a 17.86 USD y tiene una capitalización bursátil de $963M. En los últimos 12 meses ha facturado $119M con un margen de flujo de caja libre del -56.1%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in ad…
| Periodo | 2026-10 | 2026-07 | 2026-04 | 2026-02 |
|---|---|---|---|---|
| Real | — | $-0.36 | $-0.36 | $-0.19 |
| Estimado | $-0.51 | $-0.56 | $-0.45 | $-0.38 |
| Sorpresa | — | +35.7% | +20.0% | +50.0% |
| Métrica | BBNX | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 55.4% | 57.0% | -1.6% |
| Operating Margin | -71.5% | -38.6% | -32.9% |
| Net Margin | -73.0% | -33.6% | -39.5% |
| FCF Margin | -56.1% | -13.9% | -42.2% |
| ROE | -25.4% | -40.4% | +14.9% |
| ROA | -22.3% | -32.0% | +9.7% |
| Current Ratio | 8.66 | 2.84 | +5.82 |
| Debt / Equity | — | 0.28 | — |